Successful, we will reply to you quickly.

OK

Please select the quantity.

OK

Your message is being sent, please wait.

Close

test

Close

Send mail failed, please send again!

Close

Products are for research use only. Not for human use. We do not sell to patients.

Signaling Pathway

WEHI-345

HY-18937

WEHI-345

WEHI-345 Chemical Structure

WEHI-345 is a potent and selective inhibitor of RIPK2, with IC50 of 0.13 μM.

Size Price Stock Quantity
10 mM * 1 mL in DMSO $385 In-stock
5 mg $350 In-stock
10 mg $500 In-stock
50 mg $1500 In-stock
100 mg $2100 In-stock
200 mg Get quote
500 mg Get quote
Size Price Stock Quantity
10 mM * 1 mL in DMSO €377 In-stock
5 mg €343 In-stock
10 mg €490 In-stock
50 mg €1470 In-stock
100 mg €2058 In-stock
200 mg Get quote
500 mg Get quote

* Please select Quantity before adding items.

Bulk Inquiry

Inquiry Information
Product name: WEHI-345
Cat. No.: HY-18937

WEHI-345 Data Sheet

  • Network Version

    DataSheet

Related Compound Libraries

Biological Activity of WEHI-345

WEHI-345 is a potent and selective inhibitor of RIPK2, with IC50 of 0.13 μM.
IC50 value: 0.13 μM
Target: RIPK2
in vitro: WEHI-345 is a selective RIPK2 kinase inhibitor, which delays RIPK2 ubiquitylation and NF-κB activation downstream of NOD engagement. WEHI-345 is an ATP analogue and was therefore predicted to bind in the ATP-binding pocket of RIPK2. WEHI-345 proved to be highly specific for RIPK2(Kd=46 nM) and displayed negligible activity (>10 μM) against RIPK1, RIPK4 and RIPK5.
in vivo: WEHI-345 inhibits NOD signalling and has a beneficial effect on an EAE model. WEHI-345 blocks MDP-induced cytokine production. WEHI-345 ameliorates experimental autoimmune encephalomyelitis in mice. WEHI-345 also potently inhibited MDP-induced cytokine and chemokine secretion in the mouse macrophage Raw 264.7 cell line.

Protocol (Extracted from published papers and Only for reference)

More

Chemical Information

M.Wt 401.46 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C₂₂H₂₃N₇O
CAS No 1354825-58-3
Solvent & Solubility

DMSO: ≥ 32 mg/mL

Preparing Stock Solutions

1 mg 5 mg 10 mg
1 mM 2.4909 mL 12.4545 mL 24.9091 mL
5 mM 0.4982 mL 2.4909 mL 4.9818 mL
10 mM 0.2491 mL 1.2455 mL 2.4909 mL

References on WEHI-345

Inhibitor Kit

Related RIP kinase Products

  • GSK'481

    GSK(acute)481 can inhibit RIP1 WT S166 phosphorylation in human vs mouse plasmids overexpressed in HEK293T cells.

  • GSK583

    GSK583 is a highly potent and selective inhibitor of RIP2 Kinase.

  • Necrostatin-1

    Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-(alpha)-induced necroptosis with EC50 of 490 nM.

  • RIP2 kinase inhibitor 1

    RIP2 kinase inhibitor 1 is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.

  • RIP2 kinase inhibitor 2

    RIP2 kinase inhibitor 2 is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043437 A1, compound example 9.